Anthony Mancini
CIK: 0002124509
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Revolution Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Oct 26, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct2.3K shares at avg. $33.62$78K - Oct 26, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.3K shares at avg. $186.99$432K - Sep 25, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.1K shares at avg. $200.54$626K - Sep 25, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct3.1K shares at avg. $33.62$105K - Sep 24, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct587 shares at avg. $200.00$117K - Sep 18, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.8K shares at avg. $196.94$347K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct27 shares at avg. $195.05$5K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.7K shares at avg. $199.30$348K - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct300 shares at avg. $207.17$62K - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct9.4K shares at avg. $33.62$315K - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct6K shares at avg. $203.28$1.2M - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.5K shares at avg. $204.14$1.1M - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.4K shares at avg. $205.05$496K - Sep 10, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.2K shares at avg. $206.10$243K - Jun 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.6K shares at avg. $156.12$720K - May 26, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2K shares at avg. $154.06$308K - May 26, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct421 shares at avg. $154.82$65K - May 26, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct700 shares at avg. $153.30$107K - May 26, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct3.1K shares at avg. $33.62$105K - Apr 27, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.7K shares at avg. $131.66$220K - Apr 27, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1K shares at avg. $132.88$139K - Apr 27, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct400 shares at avg. $134.34$54K - Apr 27, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct3.1K shares at avg. $33.62$105K - Mar 25, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct37.5K shares at avg. $33.62$1.3M - Mar 25, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.1K shares at avg. $94.16$295K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 26, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 2,310 | $33.62 | $77,662 | Direct |
| Oct 26, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,310 | $186.99 | $431,947 | Direct |
| Sep 25, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,121 | $200.54 | $625,885 | Direct |
| Sep 25, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 3,121 | $33.62 | $104,928 | Direct |
| Sep 24, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 587 | $200.00 | $117,400 | Direct |
| Sep 18, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,764 | $196.94 | $347,402 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 27 | $195.05 | $5,266 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,747 | $199.30 | $348,183 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 300 | $207.17 | $62,152 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 9,363 | $33.62 | $314,784 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 6,019 | $203.28 | $1,223,569 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,530 | $204.14 | $1,128,870 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,420 | $205.05 | $496,224 | Direct |
| Sep 10, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,179 | $206.10 | $242,991 | Direct |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,615 | $156.12 | $720,490 | Direct |
| May 26, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,000 | $154.06 | $308,122 | Direct |
| May 26, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 421 | $154.82 | $65,177 | Direct |
| May 26, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 700 | $153.30 | $107,312 | Direct |
| May 26, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 3,121 | $33.62 | $104,928 | Direct |
| Apr 27, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,671 | $131.66 | $220,007 | Direct |
| Apr 27, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,049 | $132.88 | $139,388 | Direct |
| Apr 27, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 400 | $134.34 | $53,734 | Direct |
| Apr 27, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 3,120 | $33.62 | $104,894 | Direct |
| Mar 25, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 37,450 | $33.62 | $1,259,069 | Direct |
| Mar 25, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,128 | $94.16 | $294,520 | Direct |
1-25 of 29 transactions
About Mancini Anthony
Mancini Anthony (SEC CIK 0002124509) files insider reports with the SEC as Officer of Revolution Medicines, Inc. (RVMD).
Signal8 holds 10 ownership filings by Mancini Anthony (1 Form 3, 9 Form 4), filed between Mar 26, 2026 and Oct 28, 2026. Those filings report 29 transactions, from Mar 25, 2026 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mancini Anthony's filings is in REDWOOD CITY, CA.
Recent filings by Mancini Anthony
- Oct 26, 2026: Option exercise of RVMD shares (Form 4, code M).
- Oct 26, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Sep 25, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Sep 25, 2026: Option exercise of RVMD shares (Form 4, code M).
- Sep 24, 2026: Open-market sale of RVMD shares (Form 4, code S).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer
- GOLDSMITH MARK A